Intra Cellular Therapies



Ebitda Endring Dato
Acadia Pharmaceuticals USD 12.2M 22.01M 2024-12
ALKERMES USD 163.42M 40.22M 2024-12
Biogen USD 754.8M 7.2M 2024-12
Bristol-Myers Squibb USD 4.91B 445M 2024-12
Cytokinetics USD -136657000 1.73M 2024-12
Gilead Sciences USD 3.21B 651M 2024-12
Halozyme Therapeutics USD 195.96M 12.4M 2024-12
J&J USD 7.88B 1.76B 2025-03
Neurocrine Biosciences USD 152.1M 39.2M 2024-12
Novartis USD 6.82B 1.31B 2024-12
Prothena USD -64676000 1.61M 2024-12
RedHill Biopharma USD 2.69M 108.46M 2023-06
Supernus Pharmaceuticals USD 49.15M 11.8M 2024-12
United Therapeutics USD 383.4M 43.9M 2024-12



Intra Cellular Therapies - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.